柳州两面针股份有限公司（以下简称"公司"）于 2024 年 8 月 27 日召开第八届董事会第二十一次会议，审议通过了《关于调整第八届 董事会审计委员会委员的议案》，现将相关情况公告如下： 根据《上市公司独立董事管理办法》的规定，审计委员会成员应 当为不在上市公司担任高级管理人员的董事。为进一步完善公司治理 结构，结合公司实际情况，公司董事会对第八届董事会审计委员会部 分成员进行调整，董事、副总裁、财务总监王为民先生不再担任公司 第八届董事会审计委员会委员。公司董事会选举董事唐鹏先生为公司 审计委员会委员，与独立董事余兵先生、魏佳先生共同组成公司第八 届董事会审计委员会，余兵先生仍任主任委员，任期自本次董事会审 议通过之日起至本届董事会任期届满之日止。 证券代码：600249 证券简称：两面针 公告编号：临2024-017 柳州两面针股份有限公司 关于调整第八届董事会审计委员会委员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 柳州两面针股份有限公司 董事会 2024 年 8 月 28 日 1 特此公告。 ...

Financial Performance - The company's operating revenue for the first half of 2024 reached RMB 516,986,313.41, representing a year-on-year increase of 23.52% compared to RMB 418,555,265.44 in the same period last year[12]. - The net profit attributable to shareholders of the listed company was a loss of RMB 3,467,504.38, significantly down from a profit of RMB 998,622.54 in the previous year[12]. - The net profit after deducting non-recurring gains and losses was RMB 8,943,212.39, showing a substantial increase of 971.18% from RMB 834,892.79 in the same period last year[12]. - The net cash flow from operating activities decreased by 87.49%, amounting to RMB 633,817.73 compared to RMB 5,066,876.84 in the previous year[12]. - The total assets at the end of the reporting period were RMB 2,633,425,749.01, a slight increase of 0.44% from RMB 2,621,957,721.33 at the end of the previous year[12]. - The net assets attributable to shareholders of the listed company were RMB 2,116,382,827.84, showing a minor decrease of 0.16% from RMB 2,119,850,332.22 at the end of the previous year[12]. - The basic earnings per share for the reporting period was -0.0063, compared to 0.0018 in the same period last year[13]. - The weighted average return on net assets decreased by 0.21 percentage points to -0.16% from 0.05% in the previous year[13]. Business Operations - The company actively expanded its business, maintaining an upward trend in performance following growth in 2023, with a significant increase in comprehensive gross profit[14]. - The loss in net profit was primarily influenced by the fair value changes of the company's holdings in CITIC Securities stock[14]. - The company operates in the daily chemical industry, focusing on the research, production, and sales of oral care products, personal care items, and hotel supplies[20]. - The company has established a strong brand presence with its "Two-Headed Needle" brand recognized as a top national brand and its toothpaste awarded as a national quality standard demonstration product[23]. - The company has a robust R&D capability, holding proprietary technology in traditional Chinese medicine toothpaste and being recognized as a national high-tech enterprise[22]. - The hotel supplies segment is expanding, with the company producing eco-friendly products such as bamboo toothbrushes and recycled packaging, positioning itself as a leader in the industry[19]. - The company’s sales strategy combines online and offline channels, utilizing platforms like Tmall and JD.com, as well as direct supply to major supermarkets and hotels[21]. - The company has achieved ISO9001 certification and other international quality management certifications, ensuring high product quality standards[24]. - The company benefits from local access to abundant herbal resources, facilitating efficient raw material supply[25]. Research and Development - The company’s R&D expenses amounted to 6.97 million yuan, reflecting a growth of 3.24% compared to the previous year[29]. - The company aims to enhance consumer experience and brand image through continuous product quality improvement and innovation in the daily chemical sector[17]. - The company reported a significant increase in sales expenses, which rose to ¥48,214,563.65 from ¥41,082,396.38, an increase of 17.5%[82]. - Research and development expenses increased to ¥7,195,683.56, compared to ¥6,969,542.38 in the previous year, indicating a focus on innovation[82]. Financial Position - The company’s total assets at the end of the reporting period were significantly impacted by a fair value loss of 21.22 million yuan on financial assets, primarily from stock investments[35]. - The company’s short-term borrowings increased by 60.34% to 930 million yuan, indicating a rise in bank loans[32]. - The company’s tax liabilities increased by 161.29% to 10.10 million yuan, driven by higher VAT and corporate income tax obligations[32]. - The total assets at the end of the reporting period amount to CNY 2,098,042,295.88, reflecting the company's financial position[93]. - The total equity attributable to minority shareholders is CNY -4,718,792.37, indicating a potential area for improvement[93]. Environmental Responsibility - The company has established an environmental protection management system and has not faced any significant environmental pollution incidents during the reporting period[57]. - The company emphasizes energy conservation and emission reduction, actively participating in environmental protection initiatives[58]. - The company has implemented photovoltaic power generation equipment, promoting the use of clean energy and reducing transmission costs[58]. - Yikang Pharmaceutical has implemented effective pollution control measures, ensuring compliance with environmental standards[49]. - The company has established an emergency response plan for environmental incidents, enhancing its ability to manage potential pollution accidents[52]. Shareholder Information - The number of ordinary shareholders as of the end of the reporting period is 40,786[71]. - The largest shareholder, Guangxi Liuzhou Industrial Investment Development Group Co., Ltd., holds 183,360,652 shares, representing 33.34% of the total shares[72]. - The second largest shareholder, Liuzhou Economic Development Investment Co., Ltd., holds 32,959,167 shares, representing 5.99% of the total shares[72]. - The top ten shareholders collectively hold a significant portion of the company's shares, with no changes reported during the reporting period[73]. Government Subsidies - The company reported a government subsidy of ¥4,441,034.32, while it incurred a loss of ¥21,222,269.78 from fair value changes of financial assets and liabilities[16]. - The company received government subsidies classified into asset-related and income-related categories[200]. - Asset-related subsidies are for acquiring or constructing long-term assets, while income-related subsidies are not tied to asset acquisition[200]. - The classification of government subsidies is based on specific project budgets and their relative expenditure proportions[200]. - The financial impact of government subsidies is significant for the company's overall performance[200].

柳州两面针股份有限公司 股东大会议事规则 第一章 总 则 第一条 为了柳州两面针股份有限公司（以下简称"公司"）股东的合法 权益，提高公司股东大会议事效率，促进公司的规范运作，根据《中华人 民共和国公司法》（以下简称《公司法》）《上市公司治理准则》《上市 公司股东大会规则》等有关法律、法规、规范性文件及《柳州两面针股份 有限公司章程》（以下简称《公司章程》）的规定，制定本规则。 第二条 公司应当严格按照法律、行政法规、本规则及《公司章程》的 相关规定召开股东大会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东大会。公司全体董 事应当勤勉尽责，确保股东大会正常召开和依法行使职权。 第六条 董事会应当在本规则第四条规定的期限内按时召集股东大会。 第三条 股东大会应当在《公司法》和《公司章程》规定的范围内行使 职权。 第四条 股东大会分为年度股东大会和临时股东大会。年度股东大会每 年召开一次，应当于上一会计年度结束后的 6 个月内举行。临时股东大会 不定期召开，出现《公司章程》第 43 条规定的应当召开临时股东大会的情 形时，临时股东大会应当在 2 个月内召开。 公司在上述期限内不能召开 ...

证券代码：600249 证券简称：两面针 公告编号：临 2024-013 柳州两面针股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利 0.03 元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2024/8/7 | － | 2024/8/8 | 2024/8/8 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司 2024 年 6 月 27 日的 2023 年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本 550,000,000 股为基数，每股派发现 金红利 0.03 元 ...

Financial Performance - The company expects a net profit attributable to shareholders for the first half of 2024 to be between -500,000 and -4,500,000 RMB, indicating a loss [4]. - The previous year's earnings per share was 0.0018 RMB [6]. - The company reported a significant loss from changes in fair value of financial assets, amounting to approximately -21 million RMB, which is a deterioration from -1.24 million RMB in the same period last year [12]. - The estimated net profit attributable to shareholders, excluding non-recurring gains and losses, is projected to be between 7.5 million and 11 million RMB [15]. - The total profit for the current period is estimated at 4.01 million RMB, with a net profit attributable to shareholders of 998,600 RMB [18]. Earnings Forecast - The company has indicated that there are no major uncertainties that could affect the accuracy of the earnings forecast [20].

北京市盈科（南宁）律师事务所 法律意见书 北京市盈科（南宁）律师事务所 关于柳州两面针股份有限公司 2023 年年度 股东大会的法律意见书 盈科（桂）法意字（2024）第 L-01 号 致：柳州两面针股份有限公司 北京市盈科（南宁）律师事务所接受柳州两面针股份有限公司（以 下简称"公司"）的委托，指派本所律师对公司召开 2023 年年度股东大 会（以下简称"本次股东大会"或"会议"）的有关事项进行见证并出 具法律意见。 为出具法律意见，本所律师审查了公司提供的有关会议文件、资料， 并出席了本次股东大会进行现场见证。公司保证其已向本所律师提供了 出具法律意见所必须的、真实的、完整的书面材料。 基于对上述文件、资料的审查和现场见证情况，本所律师根据《中 华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和 国证券法》、《上市公司股东大会规则》（以下简称"《股东大会规则》"）、 《上海证券交易所上市公司股东大会网络投票实施细则》、《柳州两面 针股份有限公司章程》（以下简称"《公司章程》"）、《股东大会议 事规则》等有关规定，按照律师行业公认的业务标准、道德规范和勤勉 尽责的精神，对本次股东大会发表法律意见 ...

证券代码：600249 证券简称：两面针 公告编号：2024-011 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (五) 公司董事、监事和董事会秘书的出席情况 柳州两面针股份有限公司 2023 年年度股东大会决议公告 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 10 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 216,477,299 | | 3、出席会议的股东所持有表决权股份数占公司有 | | | 表决权股份总数的比例（%） | 39.3595 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主 持情况等。 会议由公司董事会召集，董事长林钻煌先生主持，采取现场投票 及网络投票相结合的方式召开并表决。会议的召集和召开符合《公司 法》和《公司章程》的规定，做出的决议合法、有效。 (一) 股东大会召开的时间：2024 年 6 月 27 日 (二) 股东大会召开的地点：广西柳州市东环大道 282 号两面针办 ...

柳州两面针股份有限公司（以下简称"公司"）第八届董事会、监 事会任期将于近期届满，鉴于公司第九届董事会候选人、监事会候选 人的提名工作尚未完成，预计在原定任期届满前无法完成换届工作。 为确保公司董事会、监事会相关工作的连续性和稳定性，公司第八届 董事会、监事会将延期换届，董事会各专门委员会及高级管理人员的 任期亦相应顺延。 在公司董事会、监事会换届选举完成之前，公司第八届董事会成 员、监事会成员、董事会各专门委员会成员及高级管理人员将严格按 照相关法律法规和《柳州两面针股份有限公司章程》的规定继续履行 董事、监事、董事会专门委员会委员及高级管理人员的义务和职责。 证券代码：600249 证券简称：两面针 公告编号：临2024-010 柳州两面针股份有限公司 关于董事会、监事会延期换届 及独立董事任期届满的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会、监事会延期换届 二、独立董事任期届满 根据《中华人民共和国公司法》《上市公司独立董事管理办法》 等相关规定，独立董事在上市公司连续任职时间不得超过六 ...

柳州两面针股份有限公司 2023 年年度股东大会 目录 | 2023 | 年年度股东大会会议须知 | 1 | | --- | --- | --- | | 2023 | 年年度股东大会会议安排 | 2 | | 议案一： 2023 | 年度董事会工作报告 | 3 | | 议案二： | 年度监事会工作报告 2023 | 9 | | 议案三： | 2023 年度财务决算报告 | 12 | | 议案四： | 年年度报告（全文及摘要） 2023 | 15 | | 议案五： | 2023 年度利润分配预案 | 16 | | 议案六： | 关于授权管理层贷款的议案 | 17 | | 议案七： | 关于修订公司《独立董事工作制度》的议案 18 | | | 听取：2023 | 年度独立董事述职报告 | 33 | 2 柳州两面针股份有限公司 2023 年年度股东大会会议须知 各位股东： 为了维护股东的合法权益，确保公司股东大会的会议秩序和议事 效率，保证大会顺利进行，公司根据《公司法》《证券法》《上市公 司股东大会规则》《公司章程》及《股东大会议事规则》等规定，特 制定本须知。 会议资料 股票简称：两面针 股票代码：600249 ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 207,794,818.22, representing a year-on-year increase of 10.55%[5] - The net profit attributable to shareholders was a loss of CNY 1,274,521.77, with a significant decline compared to a profit of CNY 4,587,640.30 in the same period last year[9] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 5,225,506.29, an increase from CNY 608,600.76 in the previous year[9] - The basic earnings per share for the quarter were -CNY 0.0023, a decrease from CNY 0.0083 in the same period last year[9] - Net profit for Q1 2024 was a loss of CNY 1.17 million, compared to a net profit of CNY 4.67 million in Q1 2023, representing a decline of 125.06%[21] - The company's basic earnings per share for Q1 2024 was -CNY 0.0023, down from CNY 0.0083 in Q1 2023[22] - The company reported a total profit loss of CNY 4.42 million in Q1 2024, compared to a profit of CNY 6.68 million in Q1 2023[21] Cash Flow - The net cash flow from operating activities was a negative CNY 14,258,810.76, indicating cash outflow during the quarter[5] - Cash inflow from operating activities in Q1 2024 was CNY 276.58 million, compared to CNY 210.05 million in Q1 2023, reflecting an increase of 31.6%[22] - Cash outflow from operating activities in Q1 2024 totaled CNY 290.84 million, up from CNY 227.76 million in Q1 2023, indicating a rise of 27.7%[23] - The net cash flow from operating activities for Q1 2024 was -CNY 14.26 million, an improvement from -CNY 17.71 million in Q1 2023[23] - Investment activities resulted in a net cash outflow of CNY 8.20 million in Q1 2024, compared to CNY 4.53 million in Q1 2023[23] - Total cash inflow from financing activities was $25 million, compared to $35 million in the previous period, indicating a decrease of 28.57%[24] - Cash outflow for debt repayment increased significantly to $34 million from $13 million, representing a rise of 161.54%[24] - The net cash flow from financing activities was negative at -$9.42 million, contrasting with a positive cash flow of $21.7 million in the prior period[24] - The net increase in cash and cash equivalents was -$31.88 million, compared to a slight decrease of -$531,420.43 previously[24] - The ending balance of cash and cash equivalents stood at $1.25 billion, down from $1.27 billion at the beginning of the period[24] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,622,389,607.62, showing a slight increase of 0.02% from the previous year[6] - The company's total current assets as of March 31, 2024, amounted to RMB 1,887,460,942.80, slightly up from RMB 1,883,579,504.99 at the end of 2023[14] - Cash and cash equivalents decreased to RMB 1,245,946,790.26 from RMB 1,277,823,841.14, reflecting a decline of approximately 2.5%[14] - Inventory increased significantly to RMB 296,013,647.83, up from RMB 252,292,080.98, marking a rise of about 17.3%[14] - Total liabilities as of March 31, 2024, were RMB 507,357,843.94, compared to RMB 505,751,467.09 at the end of 2023, indicating a slight increase[16] - The company's total assets reached RMB 2,622,389,607.62, a marginal increase from RMB 2,621,957,721.33 at the end of 2023[16] - The total equity attributable to shareholders was RMB 2,118,575,810.45, slightly down from RMB 2,119,850,332.22[16] - The equity attributable to shareholders was CNY 2,118,575,810.45, down 0.06% from the end of the previous year[6] Government Support and Expenses - The company received government subsidies amounting to CNY 2,740,383.68, which positively impacted the financial results[7] - Total operating costs for Q1 2024 were CNY 203.36 million, an increase of 8.16% from CNY 188.02 million in Q1 2023[20] - The company’s financial expenses in Q1 2024 were -CNY 11.06 million, compared to -CNY 5.85 million in Q1 2023, indicating a significant increase in financial costs[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 43,647[10] Product Development and Strategy - The company has not disclosed any significant new product developments or market expansion strategies during this reporting period[13] Accounting Standards - The company did not apply new accounting standards or interpretations starting in 2024[24]